"10.1371_journal.pone.0045888","none","2012-09-25T00:00:00Z","Lindsay R Ancelet; Frank E Aldwell; Fenella J Rich; Joanna R Kirman","Infectious Diseases Group, Malaghan Institute of Medical Research, Wellington, New Zealand; Immune Solutions Ltd, Centre for Innovation, University of Otago, Dunedin, New Zealand; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand","Conceived and designed the experiments: LRA FEA JRK. Performed the experiments: LRA FJR. Analyzed the data: LRA JRK. Contributed reagents/materials/analysis tools: FEA. Wrote the paper: LRA JRK.","FEA is an Inventor on a patent related to the Liporale technology and is a Director on a company (Immune Solutions Ltd) which has a vested interest in commercializing Liporale as an oral delivery platform. Liporale is covered by the following pending patents and applications: “Antigenic Compositions” WIPO WO/2003/009868 (PCT/NZ2002/00132, NZ 546141, AU 2002/326233, US 2004/0234533, EP 02760915.5, CA 2454920, ZA 2004/1211, CN 02817408.9, IN 00302/DELNP/2004, JP 2003-515260, HK 04109263.7. This study was partly commercially funded by Otago Innovations Ltd. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2012","09","Lindsay R Ancelet","LRA",4,TRUE,3,2,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
